<it>HER2 </it>Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours
<p>Abstract</p> <p>Whereas <it>HER2 </it>amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The aim of the study was to compare the frequency of <it>HER2 </it>amplifi...
Main Authors: | Brożek Izabela, Kardaś Iwona, Ochman Karolina, Dębniak Jarosław, Stukan Maciej, Ratajska Magdalena, Morzuch Lucyna, Emerich Janusz, Limon Janusz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-11-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://www.hccpjournal.com/content/4/1/39 |
Similar Items
-
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
by: Ratajska Magdalena, et al.
Published: (2012-12-01) -
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
by: Magdalena Koczkowska, et al.
Published: (2018-11-01) -
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer
by: A. Viansone, et al.
Published: (2022-10-01) -
Genetic testing for hereditary breast cancer in Poland: 1998–2022
by: Jacek Gronwald, et al.
Published: (2023-06-01) -
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
by: Katie Lin, et al.
Published: (2022-06-01)